Joel Greenblatt Biomarin Pharmaceutical Inc Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 119,446 shares of BMRN stock, worth $6.62 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
119,446
Previous 47,469
151.63%
Holding current value
$6.62 Million
Previous $3.36 Million
95.68%
% of portfolio
0.04%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding BMRN
# of Institutions
674Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$874 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$837 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$681 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...